Pharma & Healthcare

Global Lenalidomide Market Research Report 2026

This report delivers a comprehensive overview of the global Lenalidomide market, with both quantitative and qualitative analyses, to help readers develop growth strategies, assess the competitive landscape, evaluate their position in the current market, and make informed business decisions regarding Lenalidomide. The Lenalidomide market size, estimates, and forecasts are provided in terms of sales volume (K Pcs) and revenue (US$ millions), with 2025 as the base year and historical and forecast data for 2021–2032.
The report segments the global Lenalidomide market comprehensively. Regional market sizes by Type, by Application, , and by company are also provided. For deeper insight, the report profiles the competitive landscape, key competitors, and their respective market rankings, and discusses technological trends and new product developments.
This report will assist Lenalidomide manufacturers, new entrants, and companies across the industry value chain with information on revenues, sales volume, and average prices for the overall market and its sub-segments, by company, by Type, by Application, and by region.
Market Segmentation
By Company
Celgene
SL Pharma
Segment by Type
5 mg Capsules
10 mg Capsules
15 mg Capsules
25 mg Capsules
by Application
Multiple myeloma (MM)
Myelodysplastic syndromes (MDS)
Consumption by Region
North America
U.S.
Canada
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Europe
Germany
France
U.K.
Italy
Russia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
Chapter Outline
Chapter 1: Defines the scope of the report and presents an executive summary of market segments (by Type, by Application, , etc.), including the size of each segment and its future growth potential. It offers a high-level view of the current market and its likely evolution in the short, medium, and long term.
Chapter 2: Provides a detailed analysis of the competitive landscape for Lenalidomide manufacturers, covering pricing, sales and revenue shares, latest development plans, and mergers and acquisitions.
Chapter 3: Examines Lenalidomide sales and revenue at the regional and country levels. It quantifies market size and growth potential for each region and its key countries, and outlines market development, outlook, addressable space, and national market size.
Chapter 4: Analyzes segments by Type, detailing the size and growth potential of each segment to help readers identify “blue ocean” opportunities.
Chapter 5: Analyzes market segments by Application, covering the size and growth potential of each segment to help readers identify “blue ocean” opportunities in downstream markets.
Chapter 6: Profiles key players, presenting core information on leading companies, including product sales, revenue, pricing, gross margin, product portfolio/introductions, and recent developments.
Chapter 7: Reviews the industry value chain, including upstream and downstream segments.
Chapter 8: Discusses market dynamics and recent developments, including drivers, restraints, challenges and risks for manufacturers, U.S. Tariffs and relevant policy analysis.
Chapter 9: Summarizes the key findings and conclusions of the report.
1 Lenalidomide Market Overview
1.1 Product Definition
1.2 Lenalidomide by Type
1.2.1 Global Lenalidomide Market Value by Type: 2025 vs 2032
1.2.2 5 mg Capsules
1.2.3 10 mg Capsules
1.2.4 15 mg Capsules
1.2.5 25 mg Capsules
1.3 Lenalidomide by Application
1.3.1 Global Lenalidomide Market Value by Application: 2025 vs 2032
1.3.2 Multiple myeloma (MM)
1.3.3 Myelodysplastic syndromes (MDS)
1.4 Global Lenalidomide Market Size Estimates and Forecasts
1.4.1 Global Lenalidomide Revenue 2021–2032
1.4.2 Global Lenalidomide Sales 2021–2032
1.4.3 Global Lenalidomide Market Average Price (2021–2032)
1.5 Assumptions and Limitations
2 Lenalidomide Market Competition by Manufacturers
2.1 Global Lenalidomide Sales Market Share by Manufacturers (2021–2026)
2.2 Global Lenalidomide Revenue Market Share by Manufacturers (2021–2026)
2.3 Global Lenalidomide Average Price by Manufacturers (2021–2026)
2.4 Global Key Players of Lenalidomide, Industry Ranking, 2023 vs 2024 vs 2025
2.5 Global Key Manufacturers of Lenalidomide, Manufacturing Sites and Headquarters
2.6 Global Key Manufacturers of Lenalidomide, Product Types and Applications
2.7 Global Key Manufacturers of Lenalidomide, Date of Entry into the Industry
2.8 Global Lenalidomide Market Competitive Situation and Trends
2.8.1 Global Lenalidomide Market Concentration Rate
2.8.2 The Top 5 and Top 10 Global Lenalidomide Players Market Share by Revenue
2.8.3 Global Lenalidomide Market Share by Company Tier (Tier 1, Tier 2, Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Lenalidomide Market Scenario by Region
3.1 Global Lenalidomide Market Size by Region: 2021 vs 2025 vs 2032
3.2 Global Lenalidomide Sales by Region: 2021–2032
3.2.1 Global Lenalidomide Sales by Region: 2021–2026
3.2.2 Global Lenalidomide Sales by Region: 2027–2032
3.3 Global Lenalidomide Revenue by Region: 2021–2032
3.3.1 Global Lenalidomide Revenue by Region: 2021–2026
3.3.2 Global Lenalidomide Revenue by Region: 2027–2032
3.4 North America Lenalidomide Market Facts & Figures by Country
3.4.1 North America Lenalidomide Market Size by Country: 2021 vs 2025 vs 2032
3.4.2 North America Lenalidomide Sales by Country (2021–2032)
3.4.3 North America Lenalidomide Revenue by Country (2021–2032)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Lenalidomide Market Facts & Figures by Country
3.5.1 Europe Lenalidomide Market Size by Country: 2021 vs 2025 vs 2032
3.5.2 Europe Lenalidomide Sales by Country (2021–2032)
3.5.3 Europe Lenalidomide Revenue by Country (2021–2032)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Lenalidomide Market Facts & Figures by Region
3.6.1 Asia Pacific Lenalidomide Market Size by Region: 2021 vs 2025 vs 2032
3.6.2 Asia Pacific Lenalidomide Sales by Region (2021–2032)
3.6.3 Asia Pacific Lenalidomide Revenue by Region (2021–2032)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.6.13 Philippines
3.7 Latin America Lenalidomide Market Facts & Figures by Country
3.7.1 Latin America Lenalidomide Market Size by Country: 2021 vs 2025 vs 2032
3.7.2 Latin America Lenalidomide Sales by Country (2021–2032)
3.7.3 Latin America Lenalidomide Revenue by Country (2021–2032)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Lenalidomide Market Facts & Figures by Country
3.8.1 Middle East and Africa Lenalidomide Market Size by Country: 2021 vs 2025 vs 2032
3.8.2 Middle East and Africa Lenalidomide Sales by Country (2021–2032)
3.8.3 Middle East and Africa Lenalidomide Revenue by Country (2021–2032)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 U.A.E
4 Segment by Type
4.1 Global Lenalidomide Sales by Type (2021–2032)
4.1.1 Global Lenalidomide Sales by Type (2021–2026)
4.1.2 Global Lenalidomide Sales by Type (2027–2032)
4.1.3 Global Lenalidomide Sales Market Share by Type (2021–2032)
4.2 Global Lenalidomide Revenue by Type (2021–2032)
4.2.1 Global Lenalidomide Revenue by Type (2021–2026)
4.2.2 Global Lenalidomide Revenue by Type (2027–2032)
4.2.3 Global Lenalidomide Revenue Market Share by Type (2021–2032)
4.3 Global Lenalidomide Price by Type (2021–2032)
5 Segment by Application
5.1 Global Lenalidomide Sales by Application (2021–2032)
5.1.1 Global Lenalidomide Sales by Application (2021–2026)
5.1.2 Global Lenalidomide Sales by Application (2027–2032)
5.1.3 Global Lenalidomide Sales Market Share by Application (2021–2032)
5.2 Global Lenalidomide Revenue by Application (2021–2032)
5.2.1 Global Lenalidomide Revenue by Application (2021–2026)
5.2.2 Global Lenalidomide Revenue by Application (2027–2032)
5.2.3 Global Lenalidomide Revenue Market Share by Application (2021–2032)
5.3 Global Lenalidomide Price by Application (2021–2032)
6 Key Companies Profiled
6.1 Celgene
6.1.1 Celgene Company Information
6.1.2 Celgene Description and Business Overview
6.1.3 Celgene Lenalidomide Sales, Revenue, and Gross Margin (2021–2026)
6.1.4 Celgene Lenalidomide Product Portfolio
6.1.5 Celgene Recent Developments/Updates
6.2 SL Pharma
6.2.1 SL Pharma Company Information
6.2.2 SL Pharma Description and Business Overview
6.2.3 SL Pharma Lenalidomide Sales, Revenue, and Gross Margin (2021–2026)
6.2.4 SL Pharma Lenalidomide Product Portfolio
6.2.5 SL Pharma Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Lenalidomide Industry Chain Analysis
7.2 Lenalidomide Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Lenalidomide Production Mode & Process Analysis
7.4 Lenalidomide Sales and Marketing
7.4.1 Lenalidomide Sales Channels
7.4.2 Lenalidomide Distributors
7.5 Lenalidomide Customer Analysis
8 Lenalidomide Market Dynamics
8.1 Lenalidomide Industry Trends
8.2 Lenalidomide Market Drivers
8.3 Lenalidomide Market Challenges
8.4 Lenalidomide Market Restraints
8.5 Impact of U.S. Tariffs
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
List of Tables
Table 1. Global Lenalidomide Market Value by Type (US$ Million), 2025 vs 2032
Table 2. Global Lenalidomide Market Value by Application (US$ Million), 2025 vs 2032
Table 3. Global Lenalidomide Market Competitive Situation by Manufacturers in 2025
Table 4. Global Lenalidomide Sales (K Pcs) of Key Manufacturers (2021–2026)
Table 5. Global Lenalidomide Sales Market Share by Manufacturers (2021–2026)
Table 6. Global Lenalidomide Revenue (US$ Million) by Manufacturers (2021–2026)
Table 7. Global Lenalidomide Revenue Share by Manufacturers (2021–2026)
Table 8. Global Market Lenalidomide Average Price (USD/Pcs) of Key Manufacturers (2021–2026)
Table 9. Global Key Players of Lenalidomide, Industry Ranking, 2023 vs 2024 vs 2025
Table 10. Global Key Manufacturers of Lenalidomide, Manufacturing Sites and Headquarters
Table 11. Global Key Manufacturers of Lenalidomide, Product Types and Applications
Table 12. Global Key Manufacturers of Lenalidomide, Date of Entry into the Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Lenalidomide Companies by Tier (Tier 1, Tier 2, Tier 3), based on Lenalidomide Revenue, 2025
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Lenalidomide Market Size by Region (US$ Million): 2021 vs 2025 vs 2032
Table 17. Global Lenalidomide Sales by Region (K Pcs), 2021–2026
Table 18. Global Lenalidomide Sales Market Share by Region (2021–2026)
Table 19. Global Lenalidomide Sales by Region (K Pcs), 2027–2032
Table 20. Global Lenalidomide Sales Market Share by Region (2027–2032)
Table 21. Global Lenalidomide Revenue by Region (US$ Million), 2021–2026
Table 22. Global Lenalidomide Revenue Market Share by Region (2021–2026)
Table 23. Global Lenalidomide Revenue by Region (US$ Million), 2027–2032
Table 24. Global Lenalidomide Revenue Market Share by Region (2027–2032)
Table 25. North America Lenalidomide Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 26. North America Lenalidomide Sales by Country (K Pcs), 2021–2026
Table 27. North America Lenalidomide Sales by Country (K Pcs), 2027–2032
Table 28. North America Lenalidomide Revenue by Country (US$ Million), 2021–2026
Table 29. North America Lenalidomide Revenue by Country (US$ Million), 2027–2032
Table 30. Europe Lenalidomide Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 31. Europe Lenalidomide Sales by Country (K Pcs), 2021–2026
Table 32. Europe Lenalidomide Sales by Country (K Pcs), 2027–2032
Table 33. Europe Lenalidomide Revenue by Country (US$ Million), 2021–2026
Table 34. Europe Lenalidomide Revenue by Country (US$ Million), 2027–2032
Table 35. Asia Pacific Lenalidomide Revenue by Region: 2021 vs 2025 vs 2032 (US$ Million)
Table 36. Asia Pacific Lenalidomide Sales by Region (K Pcs), 2021–2026
Table 37. Asia Pacific Lenalidomide Sales by Region (K Pcs), 2027–2032
Table 38. Asia Pacific Lenalidomide Revenue by Region (US$ Million), 2021–2026
Table 39. Asia Pacific Lenalidomide Revenue by Region (US$ Million), 2027–2032
Table 40. Latin America Lenalidomide Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 41. Latin America Lenalidomide Sales by Country (K Pcs), 2021–2026
Table 42. Latin America Lenalidomide Sales by Country (K Pcs), 2027–2032
Table 43. Latin America Lenalidomide Revenue by Country (US$ Million), 2021–2026
Table 44. Latin America Lenalidomide Revenue by Country (US$ Million), 2027–2032
Table 45. Middle East and Africa Lenalidomide Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 46. Middle East and Africa Lenalidomide Sales by Country (K Pcs), 2021–2026
Table 47. Middle East and Africa Lenalidomide Sales by Country (K Pcs), 2027–2032
Table 48. Middle East and Africa Lenalidomide Revenue by Country (US$ Million), 2021–2026
Table 49. Middle East and Africa Lenalidomide Revenue by Country (US$ Million), 2027–2032
Table 50. Global Lenalidomide Sales (K Pcs) by Type (2021–2026)
Table 51. Global Lenalidomide Sales (K Pcs) by Type (2027–2032)
Table 52. Global Lenalidomide Sales Market Share by Type (2021–2026)
Table 53. Global Lenalidomide Sales Market Share by Type (2027–2032)
Table 54. Global Lenalidomide Revenue (US$ Million) by Type (2021–2026)
Table 55. Global Lenalidomide Revenue (US$ Million) by Type (2027–2032)
Table 56. Global Lenalidomide Revenue Market Share by Type (2021–2026)
Table 57. Global Lenalidomide Revenue Market Share by Type (2027–2032)
Table 58. Global Lenalidomide Price (USD/Pcs) by Type (2021–2026)
Table 59. Global Lenalidomide Price (USD/Pcs) by Type (2027–2032)
Table 60. Global Lenalidomide Sales (K Pcs) by Application (2021–2026)
Table 61. Global Lenalidomide Sales (K Pcs) by Application (2027–2032)
Table 62. Global Lenalidomide Sales Market Share by Application (2021–2026)
Table 63. Global Lenalidomide Sales Market Share by Application (2027–2032)
Table 64. Global Lenalidomide Revenue (US$ Million) by Application (2021–2026)
Table 65. Global Lenalidomide Revenue (US$ Million) by Application (2027–2032)
Table 66. Global Lenalidomide Revenue Market Share by Application (2021–2026)
Table 67. Global Lenalidomide Revenue Market Share by Application (2027–2032)
Table 68. Global Lenalidomide Price (USD/Pcs) by Application (2021–2026)
Table 69. Global Lenalidomide Price (USD/Pcs) by Application (2027–2032)
Table 70. Celgene Company Information
Table 71. Celgene Description and Business Overview
Table 72. Celgene Lenalidomide Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs), and Gross Margin (2021–2026)
Table 73. Celgene Lenalidomide Product
Table 74. Celgene Recent Developments/Updates
Table 75. SL Pharma Company Information
Table 76. SL Pharma Description and Business Overview
Table 77. SL Pharma Lenalidomide Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs), and Gross Margin (2021–2026)
Table 78. SL Pharma Lenalidomide Product
Table 79. SL Pharma Recent Developments/Updates
Table 80. Key Raw Materials Lists
Table 81. Raw Materials Key Suppliers Lists
Table 82. Lenalidomide Distributors List
Table 83. Lenalidomide Customers List
Table 84. Lenalidomide Market Trends
Table 85. Lenalidomide Market Drivers
Table 86. Lenalidomide Market Challenges
Table 87. Lenalidomide Market Restraints
Table 88. Research Programs/Design for This Report
Table 89. Key Data Information from Secondary Sources
Table 90. Key Data Information from Primary Sources
Table 91. Authors List of This Report


List of Figures
Figure 1. Product Picture of Lenalidomide
Figure 2. Global Lenalidomide Market Value by Type (US$ Million), 2021–2032
Figure 3. Global Lenalidomide Market Share by Type: 2025 & 2032
Figure 4. 5 mg Capsules Product Picture
Figure 5. 10 mg Capsules Product Picture
Figure 6. 15 mg Capsules Product Picture
Figure 7. 25 mg Capsules Product Picture
Figure 8. Global Lenalidomide Market Value by Application (US$ Million), 2021–2032
Figure 9. Global Lenalidomide Market Share by Application: 2025 & 2032
Figure 10. Multiple myeloma (MM)
Figure 11. Myelodysplastic syndromes (MDS)
Figure 12. Global Lenalidomide Revenue, (US$ Million), 2021 vs 2025 vs 2032
Figure 13. Global Lenalidomide Market Size (US$ Million), 2021–2032
Figure 14. Global Lenalidomide Sales (K Pcs), 2021–2032
Figure 15. Global Lenalidomide Average Price (USD/Pcs), 2021–2032
Figure 16. Lenalidomide Report Years Considered
Figure 17. Lenalidomide Sales Share by Manufacturers in 2025
Figure 18. Global Lenalidomide Revenue Share by Manufacturers in 2025
Figure 19. Top 5 and Top 10 Global Lenalidomide Players: Market Share by Revenue in Lenalidomide in 2025
Figure 20. Lenalidomide Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2021 vs 2025
Figure 21. Global Lenalidomide Market Size by Region (US$ Million): 2021 vs 2025 vs 2032
Figure 22. North America Lenalidomide Sales Market Share by Country (2021–2032)
Figure 23. North America Lenalidomide Revenue Market Share by Country (2021–2032)
Figure 24. U.S. Lenalidomide Revenue Growth Rate (US$ Million), 2021–2032
Figure 25. Canada Lenalidomide Revenue Growth Rate (US$ Million), 2021–2032
Figure 26. Europe Lenalidomide Sales Market Share by Country (2021–2032)
Figure 27. Europe Lenalidomide Revenue Market Share by Country (2021–2032)
Figure 28. Germany Lenalidomide Revenue Growth Rate (US$ Million), 2021–2032
Figure 29. France Lenalidomide Revenue Growth Rate (US$ Million), 2021–2032
Figure 30. U.K. Lenalidomide Revenue Growth Rate (US$ Million), 2021–2032
Figure 31. Italy Lenalidomide Revenue Growth Rate (US$ Million), 2021–2032
Figure 32. Russia Lenalidomide Revenue Growth Rate (US$ Million), 2021–2032
Figure 33. Asia Pacific Lenalidomide Sales Market Share by Region (2021–2032)
Figure 34. Asia Pacific Lenalidomide Revenue Market Share by Region (2021–2032)
Figure 35. China Lenalidomide Revenue Growth Rate (US$ Million), 2021–2032
Figure 36. Japan Lenalidomide Revenue Growth Rate (US$ Million), 2021–2032
Figure 37. South Korea Lenalidomide Revenue Growth Rate (US$ Million), 2021–2032
Figure 38. India Lenalidomide Revenue Growth Rate (US$ Million), 2021–2032
Figure 39. Australia Lenalidomide Revenue Growth Rate (US$ Million), 2021–2032
Figure 40. Taiwan Lenalidomide Revenue Growth Rate (US$ Million), 2021–2032
Figure 41. Indonesia Lenalidomide Revenue Growth Rate (US$ Million), 2021–2032
Figure 42. Thailand Lenalidomide Revenue Growth Rate (US$ Million), 2021–2032
Figure 43. Malaysia Lenalidomide Revenue Growth Rate (US$ Million), 2021–2032
Figure 44. Philippines Lenalidomide Revenue Growth Rate (US$ Million), 2021–2032
Figure 45. Latin America Lenalidomide Sales Market Share by Country (2021–2032)
Figure 46. Latin America Lenalidomide Revenue Market Share by Country (2021–2032)
Figure 47. Mexico Lenalidomide Revenue Growth Rate (US$ Million), 2021–2032
Figure 48. Brazil Lenalidomide Revenue Growth Rate (US$ Million), 2021–2032
Figure 49. Argentina Lenalidomide Revenue Growth Rate (US$ Million), 2021–2032
Figure 50. Middle East and Africa Lenalidomide Sales Market Share by Country (2021–2032)
Figure 51. Middle East and Africa Lenalidomide Revenue Market Share by Country (2021–2032)
Figure 52. Turkey Lenalidomide Revenue Growth Rate (US$ Million), 2021–2032
Figure 53. Saudi Arabia Lenalidomide Revenue Growth Rate (US$ Million), 2021–2032
Figure 54. U.A.E Lenalidomide Revenue Growth Rate (US$ Million), 2021–2032
Figure 55. Global Sales Market Share of Lenalidomide by Type (2021–2032)
Figure 56. Global Revenue Market Share of Lenalidomide by Type (2021–2032)
Figure 57. Global Lenalidomide Price (USD/Pcs) by Type (2021–2032)
Figure 58. Global Sales Market Share of Lenalidomide by Application (2021–2032)
Figure 59. Global Revenue Market Share of Lenalidomide by Application (2021–2032)
Figure 60. Global Lenalidomide Price (USD/Pcs) by Application (2021–2032)
Figure 61. Lenalidomide Value Chain
Figure 62. Channels of Distribution (Direct Vs Distribution)
Figure 63. Bottom-up and Top-down Approaches for This Report
Figure 64. Data Triangulation
Figure 65. Key Executives Interviewed
Choose Your Edition
Add to cart

Our team would be happy to assist you with your queries.

Contact us

About us

Accurate data, The latest market trends, And deeper research directions.

Our sole purpose is to provide a basis for leaders in all walks of life to make more appropriate decisions, to help companies solve existing problems and achieve business goals

Latest reports

Useful links

Our Contacts

Room 2306, T6 Fuxing World Financial Center, Kaifu District, Changsha, Hunan, China

(+86) 159 1069 5232

sales@hengceresearch.com
hengceresearch.com

Allow cookies